A director at China Pacific Insurance Group Co Ltd bought 55,000 shares at 18.467HKD and the significance rating of the trade was 57/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...
The general evaluation of CHINA PACIFIC INSU (CN), a company active in the Life Insurance industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date January 21, 2022, the closing price ...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Summary Marketline's China Life Insurance Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by China Life Insurance Company Limited since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a co...
Summary China Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company. KeyHighlights China Life Insurance Co Ltd (China Life), a subsidiary of China Life Insurance (Group) Company, offers a range of life insurance products. It provides term life insurance, whole li...
With net profit growth accelerating to 46% from 23% in 2018, no-moat China Pacific Insurance's first-quarter results were on track to deliver our full-year expectation of over 40% growth. The pickup in growth was attributable to strong investment return and the CNY 7.3 billion reduction in insurance liability reserve as a result of rising 720-day moving average 10-year government bond yield. Investment return for the quarter surged 40%, versus a 10% decline in the year-ago period. Total investme...
With net profit growth accelerating to 46% from 23% in 2018, no-moat China Pacific Insurance's first-quarter results were on track to deliver our full-year expectation of over 40% growth. The pickup in growth was attributable to strong investment return and the CNY 7.3 billion reduction in insurance liability reserve as a result of rising 720-day moving average 10-year government bond yield. Investment return for the quarter surged 40%, versus a 10% decline in the year-ago period. Total investme...
Following no-moat China Pacific Insurance's 2018 results, we retain our fair value estimate at CNY 34 per share for A shares and HKD 38 for H shares as we made little change to key assumptions. China Pacific's H shares are trading at an 18% discount to our fair value estimate and 0.8 times 2019 price/embedded value assuming 15% growth in embedded value, or EV, versus the 18% average growth over the past five years. We believe the stock is undervalued as the market remains overly concerned about ...
Following no-moat China Pacific Insurance's 2018 results, we retain our fair value estimate at CNY 34 per share for A shares and HKD 38 for H shares as we made little change to key assumptions. China Pacific's H shares are trading at an 18% discount to our fair value estimate and 0.8 times 2019 price/embedded value assuming 15% growth in embedded value, or EV, versus the 18% average growth over the past five years. We believe the stock is undervalued as the market remains overly concerned about ...
Following no-moat China Pacific Insurance's 2018 results, we retain our fair value estimate at CNY 34 per share for A shares and HKD 38 for H shares as we made little change to key assumptions. China Pacific's H shares are trading at an 18% discount to our fair value estimate and 0.8 times 2019 price/embedded value assuming 15% growth in embedded value, or EV, versus the 18% average growth over the past five years. We believe the stock is undervalued as the market remains overly concerned about ...
We think China’s latest cut in its reserve requirement ratio will have only a limited impact on the valuations of the Chinese insurers we cover. The RRR cut will affect insurance investment return and reserving charges as interest rates decline after the liquidity injection. However, we expect the negative impact on investment returns will be smaller than what the market is expecting, thanks to a five- to seven-year holding period of fixed-income investments, rising profit contribution from ...
We think China’s latest cut in its reserve requirement ratio will have only a limited impact on the valuations of the Chinese insurers we cover. The RRR cut will affect insurance investment return and reserving charges as interest rates decline after the liquidity injection. However, we expect the negative impact on investment returns will be smaller than what the market is expecting, thanks to a five- to seven-year holding period of fixed-income investments, rising profit contribution from ...
Following no-moat China Pacific Insurance, or CPIC’s, third-quarter results, we reduce our fair value estimate to CNY 34 from CNY 38 per share for A shares and to HKD 38 from HKD 43 for H shares to reflect our slower near-term premium growth assumption. With slowing premium growth and weaker investment returns, growth in CPIC's total revenue and net profits dropped to 13.6% and 16.4% for the first three quarters. Year-on-year growth in P&C insurance premium slowed to 9.3% from 16% in the first...
Following no-moat China Pacific Insurance, or CPIC’s, third-quarter results, we reduce our fair value estimate to CNY 34 from CNY 38 per share for A shares and to HKD 38 from HKD 43 for H shares to reflect our slower near-term premium growth assumption. With slowing premium growth and weaker investment returns, growth in CPIC's total revenue and net profits dropped to 13.6% and 16.4% for the first three quarters. Year-on-year growth in P&C insurance premium slowed to 9.3% from 16% in the first...
Following no-moat China Pacific Insurance, or CPIC’s, third-quarter results, we reduce our fair value estimate to CNY 34 from CNY 38 per share for A shares and to HKD 38 from HKD 43 for H shares to reflect our slower near-term premium growth assumption. With slowing premium growth and weaker investment returns, growth in CPIC's total revenue and net profits dropped to 13.6% and 16.4% for the first three quarters. Year-on-year growth in P&C insurance premium slowed to 9.3% from 16% in the fir.....
CPIC's trusted brand and extensive distribution network establish a strong foundation for steady long-term growth, thanks to continuing improvements in agent productivity and the company's stronger-than-peer capital position. However, challenges remain in the no-moat firm's near-term prospects. During the previous market downturn, CPIC steadily shifted toward focusing on the agent channel development and sales of longer-term and protection-type insurance. The firm saw industry-beating growth in ...
Net profit growth of no-moat China Pacific Insurance, or CPIC, slowed to 27% in the first half from 88% in the first quarter. The results were a bit disappointing on a decline in life insurance agent headcount, which might indicate weaker agent sales than peers, and underwriting losses in nonauto P&C insurance business. Similar to China Life, the robust bottom-line growth was primarily attributable to write-back of insurance reserve expenses. Excluding the CNY 3.7 billion decrease in insuran...
Net profit growth of no-moat China Pacific Insurance, or CPIC, slowed to 27% in the first half from 88% in the first quarter. The results were a bit disappointing on a decline in life insurance agent headcount, which might indicate weaker agent sales than peers, and underwriting losses in nonauto P&C insurance business. Similar to China Life, the robust bottom-line growth was primarily attributable to write-back of insurance reserve expenses. Excluding the CNY 3.7 billion decrease in insurance r...
Net profit growth of no-moat China Pacific Insurance, or CPIC, slowed to 27% in the first half from 88% in the first quarter. The results were a bit disappointing on a decline in life insurance agent headcount, which might indicate weaker agent sales than peers, and underwriting losses in nonauto P&C insurance business. Similar to China Life, the robust bottom-line growth was primarily attributable to write-back of insurance reserve expenses. Excluding the CNY 3.7 billion decrease in insurance r...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.